November 26, 2012

FEI Unveils Broad Correlative Microscopy Solution Set for Cell Biologists

By Combining Imaging Techniques and Efficient Workflows, Cell Biologists Could Gain a Better Understanding of the Structure and Function of Cells to Improve the Treatment of Disease

HILLSBORO, Ore., Nov. 26, 2012 (GLOBE NEWSWIRE) -- FEI (Nasdaq:FEIC) today announced a suite of solutions for correlative light and electron microscopy (CLEM). New methods in correlative microscopy from FEI bring data from different imaging techniques together automatically in minutes, giving cell biologists the precise information they need, when they need it. Scientists believe that correlating information from the cellular down to the molecular level will lead to breakthrough discoveries that improve their understanding and treatment of diseases, such as cancer, AIDS, and Parkinson's.

"Light microscopy encompasses a broad and varied set of techniques and methodologies, each with its own requirements for correlation. One workflow does not fit all," said Dominique Hubert, vice president and general manager of FEI's Life Sciences Business Unit. "We have developed a set of workflows that are flexible enough to cover a significant share of the possible applications. And we are committed to extending that coverage as the science develops."

Electron microscopy (EM) offers extremely high image resolution—1,000 or more times better than light microscopes. Light microscopes (LM) offer a wide variety of specialized techniques, such as fluorescent labeling, that can identify a single molecule or structure within a large, complex environment like the interior of a living cell. Correlating between the two techniques allows scientists to use LM to find the target and EM to explore its form and function. Correlative microscopy allows investigators to find a feature of interest faster in the EM, gain additional information about its structure down to the molecular scale, and understand relationships between the feature and its larger scale context.

The correlative microscopy solution set from FEI includes:

  • Tecnai™ with iCorr™—a fully-integrated workflow in which the light microscope is incorporated into a transmission electron microscope (TEM) column.
  • CorrSight™— an advanced light microscope dedicated to the different steps of correlative experiments, enabling researchers to image live cell dynamics and quickly fix those cells for EM.
  • MAPS—a software solution that allows correlation between the electron microscope image and an image from any other source through a simple alignment procedure.

Oregon Health and Science University's Professor Joe Gray, based in Portland, Ore., states, "Biologists want to understand the molecular events and interactions that constitute the larger scale processes we observe in cells and tissues. This will require integration of information from multiple resolution scales, for example, ultrastructural analysis of cells that reside in specific microenvironmental niches. The iCorr system allows us to quickly find fluorescently stained cells of interest using fluorescence microscopy and followed by detailed structural analysis using electron microscopy."

Roger Wepf, director of electron microscopy at the Swiss Federal Institute of Technology in Zurich (ETH Zurich), adds, "With CorrSight, sample preparation for the electron microscope is integrated with the light microscope, using on-board fixation. We identify the target structure and prepare the sample on the CorrSight light microscope platform, then transfer the sample to the electron microscope and, with a few clicks of the mouse, navigate directly the target. This is exactly what we have been missing since it allows us to reduce manual, tedious work and improve reproducibility. CorrSight and MAPS will open new applications in correlative microscopy that were not possible before."

Hubert added, "At this point, we have only glimpsed the potential of correlative microscopy. It promises to open whole new avenues of investigation into the relationships between structure and function in biological systems at the finest scale. FEI is committed to leading the expansion of this applications space by developing correlative workflow solutions for the broadest range of techniques and methodologies."

For more information about the correlative solution set from FEI, please see www.fei.com/correlative-microscopy. For a demonstration of the Tecnai with iCorr, please go to http://fei.com/tecnai_icorr. Or visit FEI at the American Society for Cell Biology Annual Meeting, December 15-19, 2012, San Francisco, Calif., booth 513.

About FEI

FEI (Nasdaq:FEIC) is a leading diversified scientific instruments company. It is a premier provider of electron- and ion-beam microscopes and solutions for nanoscale applications across many industries: industrial and academic materials research, life sciences, semiconductors, data storage, natural resources and more. With¬†more than 60 years of technological innovation and leadership, FEI has set the performance standard in transmission electron microscopes (TEM), scanning electron microscopes (SEM) and DualBeams™, which combine a SEM with a focused ion beam (FIB).¬†Headquartered in Hillsboro, Ore., USA, FEI has over 2,300 employees and sales and service operations in more than 50 countries around the world. More information can be found at: www.fei.com.

The FEI Company logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6379

FEI Safe Harbor Statement

This news release contains forward-looking statements that include statements regarding the performance capabilities and benefits of FEI's correlative solution set: Tecnai with iCorr, CorrSight, and MAPS. Factors that could affect these forward-looking statements include but are not limited to failure of the product or technology to perform as expected and achieve anticipated results, unexpected technology problems and challenges, changes to the technology, the inability of FEI, its suppliers or project partners to make the technological advances required for the technology to achieve anticipated results, the inability of customers to develop and deploy the expected new applications and our ability to manufacture, ship and deliver the tools or software as expected. Please also refer to our Form 10-K, Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission for additional information on these factors and other factors that could cause actual results to differ materially from the forward-looking statements. FEI assumes no duty to update forward-looking statements.

CONTACT: Sandy Fewkes (media contact)

         MindWrite Communications, Inc

         +1 408 224 4024

         sandy@mind-write.com

         

         FEI

         Fletcher Chamberlin (investors and analysts)

         Investor Relations

         +1 503 726 7710

         fletcher.chamberlin@fei.com


Close window | Back to top

Copyright 2014 FEI Company